Comment on "The abrupt cessation of therapeutically administered sodium oxybate (GHB) may cause withdrawal symptoms"
J Toxicol Clin Toxicol
.
2004;42(1):121-3; author reply 125-7.
doi: 10.1081/clt-120028759.
Authors
Deborah L Zvosec
,
Stephen W Smith
PMID:
15083950
DOI:
10.1081/clt-120028759
No abstract available
Publication types
Comment
Letter
Review
MeSH terms
Cataplexy / complications
Cataplexy / physiopathology
Humans
Retrospective Studies
Sodium Oxybate / adverse effects*
Substance Withdrawal Syndrome / etiology*
Substance Withdrawal Syndrome / physiopathology
Substances
Sodium Oxybate